LIMN — Liminatus Pharma Share News
0.000.00%
Last trade - 00:00NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Liminatus Pharma Announces Reverse Stock Split Of Its Common Stock
Brief: Liminatus Pharma Announces Planned Phase 1 Clinical Trial Of Iba101, A Next-Generation Cd47 Blocking Antibody
Brief: Liminatus Pharma Enters Settlement Agreement With Clear Street LLC
NASDAQ RESUMED AT 01:13 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:08 PM
Brief: Liminatus Pharma To Launch 'American BNB Strategy' Subsidiary And Target Up To $500 Mln Fund For BNB Investment As Part Of Crypto Market Initiative
Brief: Liminatus Pharma Initiates Strategic Review Of Blockchain-Integrated Treasury Strategy
Brief: Liminatus Pharma Inc - Enters Settlement Agreement With Alta Partners - SEC Filing
Brief: Liminatus Pharma Enters MoU For Pancreatic Cancer Diagnostic Kit
Brief: Liminatus Pharma Says Iba101 Advances Toward Human Trials In U.S.& Korea
US SEC sues Kraken crypto exchange over failure to register (updated)
Brief: Iris Acquisition Corp Received Notice From Nasdaq Notifying Co Failed To Comply With Periodic Filing Requirements For Continued Listing
FTX revival effort draws possible bid from VC firm Tribe Capital - Bloomberg News (updated)
Refile: UPDATE 1-SVB shutdown sends shockwaves through Silicon Valley as CEOs race to make payroll
SVB shutdown sends shockwaves through Silicon Valley as CEOs race to make payroll (updated)
Brief: Iris Acquisition Corp - On Dec 20, 2022, Co Filed With The Secretary Of State Of The State Of Delaware An Extension Amendment
Brief: Iris Acquisition Notifies Resignation Of Farooqui Not In Compliance With Nasdaq Listing Rule
Brief: Liminatus Pharma And Iris Acquisition Corp To Combine To Incorporate And Accelerate Much-Needed Cancer Treatments